Literature DB >> 19018914

Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination.

Alexander Nast1, Ricardo Erdmann, Delano Pathirana, Berthold Rzany.   

Abstract

RATIONALE: Evidence-based guidelines can make a substantial contribution to improving medical care. However, it is important to ensure that guidelines are: (1) developed in areas in which they are needed the most; and (2) translated effectively into everyday clinical practice.
OBJECTIVES: To evaluate the need for guidelines in the treatment of psoriasis vulgaris, the success of the dissemination activities undertaken to date, and the potential benefits of educational interventions in encouraging guideline compliance.
METHODS: All dermatologists working in the Berlin-Brandenburg region of Germany were invited to attend a workshop on the psoriasis treatment guidelines. Participants could take part in a survey examining the general need for psoriasis guidelines and the success of previous dissemination activities.
RESULTS: A total of 42% of survey participants had not received a copy of the guidelines prior to the workshop. Of those who had received a copy, only 15% had studied the guidelines in detail. In total, 76% of survey participants felt that physicians' low levels of confidence in administering systemic treatments had resulted in these treatment options being used less frequently than they should. Seventy-nine per cent of survey participants believed that the guidelines would be helpful in improving physicians' confidence and ultimately lead to an increased use of systemic treatments.
CONCLUSION: The results of the present study indicate that there is a great need for guidelines on the treatment of psoriasis vulgaris in Germany, especially in light of dermatologists' low levels of confidence administering systemic treatments. Strategies for broad dissemination are essential for proper guideline implementation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018914     DOI: 10.1111/j.1365-2753.2008.00971.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  4 in total

1.  [Current status of oral immunomodulatory and immunosuppressive agents].

Authors:  S Meller; A M Baran; S A Braun; N Klossowski; B Homey
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

2.  Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing.

Authors:  Harshit Nanda; Nirmaladevi Ponnusamy; Rajasree Odumpatta; Jeyaraman Jeyakanthan; Arumugam Mohanapriya
Journal:  3 Biotech       Date:  2020-01-10       Impact factor: 2.406

3.  [Modern therapy of psoriasis : evidence-based, patient-centered, goal-oriented].

Authors:  W-H Boehncke
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

4.  Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).

Authors:  Kristian Reich; Ulrich Mrowietz; Eleni Karakasili; Ina Zschocke
Journal:  Arch Dermatol Res       Date:  2014-06-04       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.